Toward the end of trading Friday, the Dow traded down 0.14% to 24,440.10 while the NASDAQ rose 0.40% to 9,322.26. The S&P also rose, gaining 0.16% to 9,322.26.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 1,577,750 cases with around 94,720 deaths. Brazil confirmed a total of over 310,080 COVID-19 cases with 20,040 deaths, while Russia reported a total of at least 326,440 confirmed cases and 3,240 deaths. In total, there were at least 5,125,610 cases of COVID-19 worldwide with over 333,380 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Real estate shares climbed 1.7% on Friday. Meanwhile, top gainers in the sector included Altisource Portfolio Solutions S.A. ASPS, up 14%, and Redfin Corporation RDFN, up 7%.
In trading on Friday, energy shares dipped 1.3%.
Top Headline
Alibaba Group Holding Ltd - ADR BABA reported better-than-expected results for its fourth quarter.
Alibaba reported quarterly earnings of $1.30 per share on Friday, which beat the analyst consensus estimate of 87 cents. The company reported quarterly sales of $16.144 billion, which beat the analyst consensus estimate of $15.200 billion. Domestic same-store sales slipped 5.7% during the quarter.
Equities Trading UP
LiveRamp Holdings, Inc. RAMP shares shot up 23% to $47.74 after reporting upbeat Q4 results.
Shares of Sundial Growers Inc. SNDL got a boost, shooting 42% to $0.861 after gaining over 9% on Thursday.
Navidea Biopharmaceuticals, Inc. NAVB shares were also up, gaining 92% to $2.4398 after the company announced positive preliminary results from the second interim analysis of its ongoing NAV3-31 Phase 2B study.
Equities Trading DOWN
Recon Technology, Ltd. RCON shares tumbled 45% to $2.0301 after the company reported pricing of approximately $2.1 million registered direct offering.
Shares of Hewlett Packard Enterprise Company HPE were down 11% to $9.22 after the company reported weaker-than-expected Q2 results. The company also announced plans temporarily slash salaries and carry out job cuts.
Syndax Pharmaceuticals, Inc. SNDX was down, falling 18% to $16.72 after the company said a late-stage study that evaluated its investigational compound entinostat along with exemestane in patients with HR+, HER2- breast cancer who have progressed on a non-steroidal aromatase inhibitor did not achieve the primary endpoint of demonstrating a statistically significant overall survival benefit over hormone therapy alone.
Commodities
In commodity news, oil traded down 1.8% to $33.30, while gold traded up 0.7% to $1,733.20.
Silver traded up 1.6% Friday to $17.635, while copper fell 1.6% to $2.3925.
Euro zone
European shares closed mixed today. The eurozone’s STOXX 600 slipped 0.03%, the Spanish Ibex Index rose 0.17%, while Italy’s FTSE MIB Index rose 1.34%. Meanwhile, the German DAX gained 0.07%, and the French CAC 40 slipped 0.02% while UK shares fell 0.37%.
Economics
The total number of active U.S. oil rigs slipped by 21 to 237 rigs this week, Baker Hughes Inc reported.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.